Table 1.
Study | number of patients | number of implants | Implant type | One-stage/ two-stage | Implant surface | Followup (mo) | Baseline bonelevel (mm) | Bone gain (mm) | Perforation of sinus (%) | Survival (%) |
---|---|---|---|---|---|---|---|---|---|---|
Ellegaard et al. [1] | 24 | 26 | Astra | Two-stage | TiO2-blasted | 29,9 (average) | ≥3 | “Bone gain in most of the implants” | “In a few cases away from the implant site” | 95% |
12 | ITI | Two-stage | Solid screw | 25,3 (average) | 86% | |||||
Lundgren et al. [14] | 10 | 19 | TiUnite | Two-stage | Anodic oxidized | 12 | 7 (range 4–10) | “In all patients bone formation was seen” | Perforation is described but ND | 100% |
Ellegaard et al. [15] | 68 | 59 | Astra | Two-stage | TiO2-blasted | 64.2 (0–128) | ≥3 | ND | ND | 10 yrs 85.4% |
72 | ITI | One-stage | Solid screw | 57.5 (0–143) | 10 yrs 79.9% | |||||
Chen et al. [16] | 33 | 18 | ITI and Swissplus | One-stage | ND | 24 | 7.5 ± 2.1 | 4.5 (range 3–9) | 0 | 100% |
29 | Frialit-2 | Two-stage | ND | |||||||
Thor et al. [17] | 20 | 44 | Astra | Two-stage | TiO2-blasted | 14–45 | range 2–9 | 6.51 (range 4–10) | 41 | 97.7% |
Hatano et al. [18] | 6 | 14 | TiUnite | Two-stage | Anodic oxidized | 12–34 | range 2–10 | ND | 0 | 92,9% |
Sohn et al. [19] | 10 | 21 | Seven | Two-stage | Sand-blasted and acid-etched | 8.5 (range 6–12) | 5 (range 1–9) | “All cases revealed bone formation” | Perforation is described but ND | 100% |
Balleri et al. [20] | 15 | 28 | Astra | Two-stage | TiO2-blasted | 12 | 6.2 (range 4–10) | 5.5 (range 3–8.2) | 3 cases unknown number of sinuses | 100% |
Lin et al. [21] | 44 | 80 | ITI, Swissplus and Frialit-2 | Mixed | ND | 60 | 5.1 (range 4.6–6.6) | 7.4 (range 5.7–9.1) | ND | 100% |
Cricchio et al. [22] | 84 | 179 | TiUnite | Two-stage | Anodic oxidized | 12–72 | 5,7 (range 3.4–8) | 5,2 (range 3–7.4) | 11 | 99% |
ND: no data.